Leaflet: information for the user

Sevikar 20 mg/5 mg film-coated tablets

Olmesartan medoxomil/Amlodipine

Read this leaflet carefully before you start taking this medicine, because it contains important information for you.

-Keep this leaflet, as you may need to read it again.

-If you have any questions, ask your doctor or pharmacist.

-This medicine has been prescribed for you only. Do not give it to others even if they have the same symptoms as you, as it may harm them.

-If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

1. What Sevikar is and what it is used for

2. What you need to know before you start taking Sevikar

3. How to take Sevikar

4. Possible side effects

5. Storage of Sevikar

6. Contents of the pack and additional information

Sevikar contains two substances called olmesartan medoxomil and amlodipine (as amlodipine besylate). The two substances help control high blood pressure.

• Olmesartan medoxomil belongs to a group of medications called “angiotensin II receptor antagonists”, which decrease blood pressure by relaxing blood vessels.
• Amlodipine belongs to a group of medications called “calcium channel blockers”. Amlodipine prevents calcium from entering the blood vessel wall, preventing blood vessel constriction, which also decreases blood pressure.

The action of both substances contributes to preventing blood vessel constriction, allowing blood vessels to relax and blood pressure to decrease.

Sevikar is used to treat high blood pressure in patients whose blood pressure is not adequately controlled with olmesartan medoxomil or amlodipine alone.

Do not take Sevikar

• If you are allergic to olmesartan medoxomil, or to amlodipine, or to a special group of calcium channel blockers called dihydropyridines, or to any of the other components of this medication (listed in section 6).

Inform your doctor before taking Sevikar if you think you may be allergic.

• If you are more than 3 months pregnant. It is best to avoid Sevikar at the beginning of pregnancy (see section “Pregnancy and breastfeeding”).
• If you have diabetes or kidney failure and are being treated with a blood pressure medication that contains aliskiren.
• If you have severe liver problems, if your bile secretion is altered, or if your bile release is blocked (for example, by gallstones), or if you have jaundice (yellowing of the skin and eyes).
• If you have very low blood pressure.
• If you have inadequate blood flow to your tissues, with symptoms such as low blood pressure, weak pulse, rapid heart rate (shock, including cardiogenic shock). Cardiogenic shock means shock due to severe heart problems.
• If the blood flow to your heart is blocked (for example, due to aortic stenosis).
• If you have poor heart function (producing difficulty breathing, or peripheral edema) after a heart attack (acute myocardial infarction).

Warnings and precautions

Consult your doctor or pharmacist before starting to use Sevikar.

Tell your doctorif you are taking any of the following medications used to treat high blood pressure (hypertension):

• An angiotensin-converting enzyme inhibitor (ACE inhibitor) (for example, enalapril, lisinopril, ramipril), particularly if you have kidney problems related to diabetes.
• Aliskiren.

Your doctor may monitor your kidney function, blood pressure, and electrolyte levels in your blood (such as potassium) at regular intervals.

See also the information under the heading “Do not take Sevikar”.

Tell your doctorif you have any of the following health problems:

• Kidney problems or a kidney transplant.
• Liver disease.
• Heart failure or problems with heart valves or heart muscle.
• Severe vomiting, diarrhea, treatment with high doses of medications that increase urine production (diuretics), or if you are on a low-sodium diet.
• High levels of potassium in your blood.
• Problems with the adrenal glands (glands that produce hormones located above the kidneys).

Contact your doctor if you experience severe diarrhea, persistent diarrhea that causes significant weight loss. Your doctor will evaluate your symptoms and decide how to continue your treatment for high blood pressure.

Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking Sevikar. Your doctor will decide whether to continue treatment. Do not stop taking Sevikar on your own.

As with any other medication that lowers blood pressure, excessive lowering of blood pressure in patients with altered blood flow to the heart or brain may cause a heart attack or stroke. Therefore, your doctor will closely monitor your blood pressure.

Inform your doctor if you are pregnant or think you may be pregnant. Sevikar is not recommended for use at the beginning of pregnancy, and it should not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used during this period (see section “Pregnancy and breastfeeding”).

Children and adolescents (under 18 years)

Sevikar is not recommended for children and adolescents under 18 years.

Use of Sevikar with other medications

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any of the following medications:

• Other blood pressure-lowering medications,as they may increase the effect of Sevikar.

Your doctor may need to adjust your dose and/or take other precautions:

If you are taking an ACE inhibitor or aliskiren (see also the information under the headings “Do not take Sevikar” and “Warnings and precautions”).

• Potassium supplements, salt substitutes containing potassium, medications that increase urine production (diuretics), orheparin(to thin the blood and prevent blood clots). The use of these medications with Sevikar may increase potassium levels in the blood.
• Thelithium(medication used to treat mood changes and some types of depression) used with Sevikar may increase its toxicity. If you need to take lithium, your doctor will measure your lithium levels in the blood.
• Thenonsteroidal anti-inflammatory drugs (NSAIDs)(medications used to relieve pain, swelling, and other symptoms of inflammation, including arthritis) used with Sevikar may increase the risk of kidney failure. The effect of Sevikar may be reduced by NSAIDs.
• Colesevelam hydrochloride,a medication that lowers cholesterol levels in the blood, as it may reduce the effect of Sevikar. Your doctor may advise you to take Sevikar at least 4 hours before colesevelam hydrochloride.
• Certain antacids,as they may slightly reduce the effect of Sevikar.
• Medications used to treat HIV/AIDS(e.g. ritonavir, indinavir, nelfinavir)or fungal infections(e.g. ketoconazole, itraconazole).
• Diltiazem,verapamil(medications used to treat heart rhythm problems and high blood pressure).
• Rifampicin,erythromycin, clarithromycin (antibiotics),medications used to treat tuberculosis or other infections.
• St. John's Wort(Hypericum perforatum), herbal remedy.
• Dantrolene(in infusion for severe body temperature abnormalities).
• Simvastatin,a medication used to lower cholesterol and triglyceride levels in the blood.
• Tacrolimus, sirolimus, temsirolimus, everolimus, and ciclosporin,used to control the body's immune response, making it possible for your body to accept the transplanted organ.

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.

Taking Sevikar with food and drinks

Sevikar can be taken with or without food. Take the tablets with a little liquid (such as a glass of water). If possible, take the daily dose at the same time each day, for example, at breakfast time.

People taking Sevikar should not consume grapefruit or grapefruit juice. This is because grapefruit and grapefruit juice may cause an increase in the blood levels of the active ingredient amlodipine, which may cause an unpredictable increase in the blood pressure-lowering effect of Sevikar.

Older patients

If you are over 65 years old, your doctor will regularly monitor your blood pressure each time you increase the dose, to ensure that it does not decrease too much.

Black patients

As with other similar medications, the blood pressure-lowering effect of Sevikar is somewhat less in black patients.

Pregnancy and breastfeeding

Pregnancy

Inform your doctor if you are pregnant or think you may be pregnant.

Your doctor will advise you to stop taking Sevikar before becoming pregnant or as soon as you know you are pregnant, and will advise you to take another medication instead of Sevikar. Sevikar is not recommended for use at the beginning of pregnancy, and it should not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used during this period.

If you become pregnant while taking Sevikar, inform and visit your doctor immediately.

Breastfeeding

Inform your doctor if you are breastfeeding or planning to start breastfeeding. Amlodipine has been shown to pass into breast milk in small amounts. Sevikar is not recommended for mothers who are breastfeeding, and your doctor may choose another treatment if you wish to breastfeed, especially if your baby is newborn or premature.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Driving and operating machinery

During high blood pressure treatment, you may experience drowsiness, feel sick or dizzy, or have a headache. If this occurs, do not drive or operate machinery until the symptoms have disappeared. Consult your doctor.

This medication contains less than 1 mmol of sodium (23 mg) per coated tablet; it is essentially “sodium-free”.

Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again..

• The recommended dose of Sevikar is one tablet per day.
• Tablets can be taken with or without food. Take the tablets with a little liquid (such as a glass of water). Do not chew the tablet. Do not take Sevikar with grapefruit juice.
• Try to take your daily dose at the same time each day, for example at breakfast time.

If you take more Sevikar than you should

If you take more tablets than you should, you will probably experience a drop in blood pressure, accompanied by symptoms such as dizziness, and a rapid or slow heart rate.

If you take more tablets than you should or a child accidentally ingests some tablets, contact your doctor immediately or go to the nearest emergency center and bring the medication packaging or this leaflet with you.

Excess fluid may accumulate in the lungs (pulmonary edema) causing breathing difficulties that may develop up to 24-48 hours after ingestion.

In case of overdose or accidental ingestion, consult the Toxicological Information Service. Phone91 562 04 20.

If you forget to take Sevikar

If you forget to take a dose, take the usual dose the next day.Do nottake a double dose to make up for the missed doses.

If you interrupt treatment with Sevikar

It is essential to continue taking Sevikar, unless your doctor tells you to stop treatment.

Ask your doctor or pharmacist if you have any other questions about using this medication.

Like all medicines, this medicine can cause side effects, although not everyone will experience them. If they occur, they are often mild and do not require interrupting treatment.

The following side effects can be serious, although they may affect only a small group of people:

During treatment with Sevikar, allergic reactions can occur, which can affect the entire body, with inflammation of the face, mouth, and/or larynx (vocal cords), along with itching and skin rash.If this happens, stop taking Sevikar and consult your doctor immediately.

Sevikar can cause a pronounced drop in blood pressure in susceptible patients, or as a result of an allergic reaction. This can cause dizziness or severe drowsiness.If this happens, stop taking Sevikar, consult your doctor immediately, and remain lying down in a horizontal position.

Unknown frequency: If you experience yellowing of the whites of the eyes, dark urine, skin itching, even if you started treatment with Sevikar a long time ago,contact your doctor immediatelywho will evaluate your symptoms and decide how to continue treatment for high blood pressure.

Other possible side effects with Sevikar:

Frequent (can affect up to 1 in 10 people):

Dizziness; headache; swelling of the ankles, feet, legs, hands, or arms; fatigue.

Infrequent (can affect up to 1 in 100 people):

Dizziness when standing up; lack of energy; tingling or numbness of the hands or feet; vertigo; feeling the heartbeat; rapid heartbeat; low blood pressure with symptoms such as dizziness, drowsiness; difficulty breathing; cough; nausea; vomiting; indigestion; diarrhea; constipation; dry mouth; abdominal pain; skin rash; muscle cramps; arm and leg pain; back pain; sensation of urgency to urinate; sexual inactivity; inability to achieve or maintain an erection; weakness.

Also, some changes have been observed in the results of certain blood tests:

Increased, as well as decreased, levels of potassium in the blood, increased levels of creatinine in the blood, increased levels of uric acid, increased values of liver function tests (gamma-glutamyl transferase levels).

Rare (can affect up to 1 in 1,000 people):

Medication hypersensitivity; fainting; flushing and feeling of heat in the face; red itchy rash (urticaria); facial inflammation.

Side effects reported with the use of olmesartan medoxomil or amlodipine alone, but not with Sevikar, or with a higher frequency:

Olmesartan medoxomil

Frequent (can affect up to 1 in 10 people):

Bronchitis; sore throat; congestion and nasal secretion; cough; abdominal pain; viral gastroenteritis; diarrhea; indigestion; nausea; joint and bone pain; back pain; blood in the urine; urinary tract infection; chest pain; flu-like symptoms; pain. Changes in blood test results, such as increased levels of a type of fat (hypertriglyceridemia); increased uric acid and urea in the blood, and increased values of liver and muscle function tests.

Infrequent (can affect up to 1 in 100 people):

Reduction in the number of a type of blood cell, called platelets, which can cause easy bruising or prolong bleeding time; rapid allergic reactions, which can affect the entire body and cause respiratory problems, as well as rapid drop in blood pressure, which can even cause fainting (anaphylactic reactions);angina (chest pain or discomfortknown as angina pectoris); itching;skin rash;allergic skin rash;urticaria;facial swelling;muscle pain;discomfort.

Rare (can affect up to 1 in 1,000 people):

Facial, mouth, and/or laryngeal (vocal cord) inflammation; acute renal failure and renal insufficiency; lethargy; intestinal angioedema: swelling in the intestine that occurs with symptoms such as abdominal pain, nausea, vomiting, and diarrhea.

Amlodipine

Very frequent (can affect more than 1 in 10 people):

Edema (fluid retention).

Frequent (can affect up to 1 in 10 people):

Abdominal pain; nausea; ankle swelling; feeling of sleepiness; flushing and feeling of heat in the face, visual disturbances (including double vision and blurred vision), feeling the heartbeat, diarrhea, constipation, indigestion, muscle cramps, weakness, difficulty breathing.

Infrequent (can affect up to 1 in 100 people):

Difficulty sleeping; sleep disorders; mood changes, including anxiety;depression;irritability;shakiness;alterations in taste; fainting;ringing in the ears(tinnitus);emergenceof angina pectoris(chest painordiscomfort); irregular heartbeat;nasal secretion or congestion; hair loss;purple spotsor patcheson the skin due to small hemorrhages(purpura);skin discoloration;excessive sweating;skin rash;itching;red itchy rash (urticaria);joint or muscle pain;urination problems;need to urinate at night;increased need to urinate,enlargement of the breasts in men,chest pain;pain;discomfort;weight gain or loss.

Rare (can affect up to 1 in 1,000 people):

Confusion.

Very rare (can affect up to 1 in 10,000 people):

Reduction in the number of white blood cells, which could increase the risk of infections; reduction in the number of a type of blood cell called platelets, which could cause bruising and prolong bleeding time; increased glucose in the blood; increased muscle tension or increased resistance to passive movement(hypertonia);tingling or numbness of the hands or feet; heart attack; inflammation of blood vessels; inflammation of the liver or pancreas; inflammation of the stomach wall; gum thickening; elevated liver enzymes; yellow skin and eyes; increased skin sensitivity to light; severe allergic reactions, itching, rash, facial, mouth, and/or laryngeal (vocal cord) inflammation, along with itching and rash, severe skin reactions, including intense skin rash, urticaria, skin redness, severe itching, blisters, peeling, and inflammation of the skin, inflammation of mucous membranes (Stevens-Johnson syndrome, toxic epidermal necrolysis) sometimes very severe.

Unknown frequency (cannot be estimated from available data):

Tremors, rigid posture, mask-like face, slow movements, and unsteady gait dragging the feet.

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.

No special storage conditions are required.

Do not dispose of medications through drains or trash. Dispose of packaging and unused medications at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.

Composition of Sevikar

The active principles are olmesartan medoxomil and amlodipine (as besilate).

Each tablet contains 20 mg of olmesartan medoxomil and 5 mg of amlodipine (as besilate).

The other components are:

Tablet core: Pregelatinized maize starch, silica crystallized microcrystalline cellulose, sodium croscarmellose, and magnesium stearate.

Tablet coating: Poly (vinyl alcohol), macrogol 3350, talc, and titanium dioxide (E-171).

Appearance of the product and contents of the package

Sevikar 20 mg/5 mg film-coated tablets are white, round tablets with the inscription C73 on one side.

Sevikar film-coated tablets are available in packages of 14, 28, 30, 56, 90, 98, 10 x 28, 10 x 30 film-coated tablets, and in packages with pre-cut single-dose blisters of 10, 50, and 500 film-coated tablets.

Not all packages are marketed.

Marketing Authorization Holder

DAIICHI SANKYO ESPAÑA, S.A.

Paseo del Club Deportivo nº1,

Edificio 14, Ground floor left

28223 Pozuelo de Alarcón – Madrid

Spain

Responsible for manufacturing

DAIICHI SANKYO EUROPE GmbH

Luitpoldstrasse 1

85276 Pfaffenhofen

Germany

or

BERLIN-CHEMIE AG

Glienicker Weg 125,

12489 Berlin

Germany

or

LABORMED-PHARMA S.A.

Bd. Theodor Pallady nr. 44B, sector 3

Bucharest, cod 032266

Romania

This medicine is authorized in the member states of the European Economic Area with the following names:

Austria: Sevikar 20 mg/5 mg

Belgium: Sevikar 20 mg/5 mg

Denmark: Sevikar 20 mg/5 mg

Germany: Sevikar 20 mg/5 mg

Greece: Sevikar (20+5) mg

Finland: Sevikar 20 mg/5 mg

France: Sevikar 20 mg/5 mg

Iceland: Sevikar 20 mg/5 mg

Ireland: Sevikar 20 mg/5 mg

Italy: Sevikar 20 mg/5 mg

Luxembourg: Sevikar 20 mg/5 mg

Netherlands: Sevikar 20 mg/5 mg

Norway: Sevikar 20 mg/5 mg

Portugal: Sevikar 20 mg + 5 mg

Romania: Sevikar 20 mg/5 mg

Spain: Sevikar 20 mg/5 mg

United Kingdom: Sevikar 20 mg/5 mg

Last review date of this leaflet: January 2025.

Other sources of information

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/.